DeutschNewstral
Article
Mmarketwatch.com on 2019-12-10 19:30
Peloton shares could be headed to $5, short-seller Citron Research says
Related news
- MMallinckrodt’s stock tumbles as short seller Citron claims next victimmarketwatch.com
- HShort-seller Citron Research steps up its attack on TransDigm Group Inc.home.crainscleveland.com
- MUPDATE: Exact Sciences Corp. stock drops 3% after short-seller Citron Research targets its colon cancer testmarketwatch.com
Peloton stock tumble continues after short-seller values it at $5New York Post- MTransDigm extends recent losses after short seller Citron weighs inmarketwatch.com
- MTesla shares rocket 5% as short seller Citron reverses positionmarketwatch.com
Andrew Left’s Citron Will Stop
Publishing Short-Seller Reportswsj.com- MWayfair's stock sinks after short seller Citron takes aimmarketwatch.com
- Short seller Citron switches to long position on Tesla sharesNew York Post
- MLigand Pharma stock tanks after short seller Citron calls it 'pipe dream'marketwatch.com
- MShort seller Citron ‘scratching our heads’ at Mobileye’s buyout by Intelmarketwatch.com
- MShort-seller Citron 'scratching our heads' at Mobileye buyout but is moving onmarketwatch.com
Citron Research’s Andrew Left: Meet the short seller behind those negative reports on Valeant Pharmaceuticals Incbusiness.financialpost.com- MIGC stock rockets, but pares some gains after short-seller Citron takes aimmarketwatch.com
- BShort-Seller Citron Research Says to Buy Netflix Shares. Really.barrons.com
BlackBerry jumps after Citron Research cites ‘game changer’ techThe Globe and Mail- FShort seller sets sights on Mallinckrodtft.com
- MTwitter is the ‘Harvey Weinstein of social media,’ short seller saysmarketwatch.com
Valeant Plunges 30% After Short Seller Citron Research Makes Fraud AllegationForbes- MAfter GameStop, Andrew Left says Citron will no longer write short selling reportsmarketwatch.com